Dok-1 and Dok-2 are negative regulators of T cell receptor signaling

Interaction of the TCR complex with self- or foreign peptides is a central event in the immune responses. Upon TCR stimulation, a protein–tyrosine kinase (PTK), ZAP-70, is recruited to signaling units of the TCR complex, such as TCRζ, to play an essential role in T cell activation. Here, we find tha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International immunology 2007-04, Vol.19 (4), p.487-495
Hauptverfasser: Yasuda, Tomoharu, Bundo, Kenji, Hino, Ayako, Honda, Kazuho, Inoue, Akane, Shirakata, Masaki, Osawa, Mitsujiro, Tamura, Toshiki, Nariuchi, Hideo, Oda, Hideaki, Yamamoto, Tadashi, Yamanashi, Yuji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Interaction of the TCR complex with self- or foreign peptides is a central event in the immune responses. Upon TCR stimulation, a protein–tyrosine kinase (PTK), ZAP-70, is recruited to signaling units of the TCR complex, such as TCRζ, to play an essential role in T cell activation. Here, we find that mice lacking adaptor proteins Dok-1 and Dok-2 show augmented responses to thymus-dependent, but not thymus-independent, antigens, and that their T cells show elevated responses to TCR stimulation, including the activation of ZAP-70 and subsequent proliferation and cytokine production. Furthermore, the forced expression of Dok-1 or Dok-2 in a CD3+CD4+ T cell clone inhibited the activation of ZAP-70 upon TCR stimulation. Interestingly, the Dok-1 and Dok-2 COOH-terminal moieties bearing the src homology 2 target motifs were dispensable for this negative regulation, even though they are crucial for the known adaptor function of Dok-family proteins. Thus, by an as yet unidentified mechanism, Dok-1 and Dok-2 play an essential role in the negative regulation of TCR signaling. Consistently, all mice lacking these proteins exhibited elevated titers of antibodies to double-stranded DNA and developed lupus-like renal disease.
ISSN:0953-8178
1460-2377
DOI:10.1093/intimm/dxm015